UK markets closed

Theriva Biologics, Inc. (SFY.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.3560-0.0140 (-3.78%)
At close: 08:20AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
14,311
14,311
11,723
7,800
5,131
Selling general and administrative
7,120
7,120
9,858
6,474
5,029
Total operating expenses
21,431
21,431
21,581
14,274
10,160
Operating income or loss
-21,431
-21,431
-21,581
-14,274
-10,160
Total other income/expenses net
3
3
-41
-
-
Income before tax
-19,989
-19,989
-21,110
-14,268
-10,116
Income tax expense
-1,640
-1,640
-1,425
0
-
Income from continuing operations
-18,349
-18,349
-19,685
-14,268
-10,116
Net income
-18,349
-18,349
-19,685
-14,267
-10,043
Net income available to common shareholders
-18,349
-18,349
-20,025
-23,189
-12,557
Basic EPS
-1.25
-1.14
-1.31
-1.90
-6.60
Diluted EPS
-1.25
-1.14
-1.31
-1.90
-6.60
Basic average shares
15,783
16,107
15,327
12,188
1,901
Diluted average shares
15,783
16,107
15,327
12,188
1,901